Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 4/20 | 0.37 |
| ▸ | LAP3 | P28838 | 1/20 | 0.37 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.37 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.37 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.36 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.36 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.36 |
| ▸ | FDPS | P14324 | 4/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | RRM1 | P23921 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6770895 | 0.81 | TP53 (0.47) | TP53SPHK1CA2LAP3GRIK1 | |
| SCHEMBL6769831 | 0.76 | TP53 (0.39) | TP53CA2FDPSGPR84FFAR1 | |
| Sulfuric Acid SCHEMBL28890625 | 0.73 | TP53 (0.55) | TP53SPHK1CA2LAP3GRIK1 | |
| Sulfuric Acid SCHEMBL18952165 | 0.71 | TP53 (0.58) | TP53SPHK1CA2LAP3GRIK1 | |
| SCHEMBL17180033 | 0.71 | TP53 (0.48) | TP53SPHK1CA2LAP3GRIK1 | |
| Sulfuric Acid SCHEMBL2558701 | 0.71 | TP53 (0.58) | TP53SPHK1CA2LAP3GRIK1 | |
| Sulfuric Acid SCHEMBL2139560 | 0.71 | TP53 (0.58) | TP53SPHK1CA2LAP3GRIK1 | |
| Sulfuric Acid SCHEMBL2558699 | 0.71 | TP53 (0.58) | TP53SPHK1CA2LAP3GRIK1 | |
| Sulfuric Acid SCHEMBL4377467 | 0.71 | TP53 (0.58) | TP53SPHK1CA2LAP3GRIK1 | |
| Sulfuric Acid SCHEMBL16161323 | 0.71 | TP53 (0.58) | TP53SPHK1CA2LAP3GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040197293-A1 | Anionic polyurethanes with elastic property | L'OREAL S.A. (FR) | 2004-10-07 | — | — | US | claimed |
| US-20040197293-A1 | Anionic polyurethanes with elastic property | L'OREAL S.A. (FR) | 2004-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040197293-A1 | Anionic polyurethanes with elastic property | PUF60, PHOSPHO1, PLA2G2C | TP53 2408/4885SPHK1 4364/4885CA2 977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.